Literature DB >> 26242529

The Vaccine and Cervical Cancer Screen (VACCS) project: Linking cervical cancer screening to HPV vaccination in the South-West District of Tshwane, Gauteng, South Africa.

Leon C Snyman1, Greta Dreyer, Matthys H Botha, Frederick Haynes van der Merwe, Piet J Becker.   

Abstract

BACKGROUND: Cervical cancer is preventable, but still highly prevalent in South Africa (SA). Screening strategies in the country have been ineffective, and new ways to prevent the disease are needed.
OBJECTIVES: To investigate the feasibility of linking cervical cancer screening in adult women to human papillomavirus (HPV) vaccination in schoolgirls.
METHODS: Ten primary schools in the South-West District of Tshwane, Gauteng Province, SA, took part in the study. Cervical cancer and HPV vaccine information was provided to schoolgirls and their parents. Consented schoolgirls were vaccinated and their female parents were invited to participate in self-screening.
RESULTS: Among 1 654 girls invited for vaccination, the consented and invited uptake rates were 99.4% and 64.0%, respectively. Vaccine completion rates were higher in schools where the vaccination programme was completed in the same calendar year than in those where it was administered over two calendar years. Of 569 adult females invited, 253 (44.5%) returned screen tests; 169 (66.8%) tested negative and 75 (29.6%) positive for any high-risk HPV (hrHPV). There were no differences in level of education, employment status or access to healthcare between women with positive and those with negative screen results.
CONCLUSIONS: Implementation of HPV vaccination in a primary school-based programme was successful, with high vaccine uptake and completion rates. Self-screening reached the ideal target group, and it is possible to link cervical cancer screening to the cervical cancer vaccine by giving women the opportunity of self-sampling for hrHPV testing. This is a novel and feasible approach that would require some adaptive strategies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26242529     DOI: 10.7196/samj.8418

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

1.  The Outcomes of an Educational Program Involving Men as Motivators to Encourage Women to Be Screened for Cervical Cancer.

Authors:  Jeniffer Rwamugira; Johanna E Maree; Nokuthula Mafutha
Journal:  J Cancer Educ       Date:  2019-04       Impact factor: 2.037

2.  Cervical cancer knowledge and screening uptake by marginalized population of women in inner-city Durban, South Africa: Insights into the need for increased health literacy.

Authors:  Jennifer F Ducray; Colette M Kell; Jyotika Basdav; Firoza Haffejee
Journal:  Womens Health (Lond)       Date:  2021 Jan-Dec

Review 3.  Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?

Authors:  Edina Amponsah-Dacosta; Ntombifuthi Blose; Varsetile Varster Nkwinika; Viola Chepkurui
Journal:  Front Public Health       Date:  2022-01-31

4.  Implementation research on noncommunicable disease prevention and control interventions in low- and middle-income countries: A systematic review.

Authors:  Celestin Hategeka; Prince Adu; Allissa Desloge; Robert Marten; Ruitai Shao; Maoyi Tian; Ting Wei; Margaret E Kruk
Journal:  PLoS Med       Date:  2022-07-25       Impact factor: 11.613

5.  Comparison of school based and supplemental vaccination strategies in the delivery of vaccines to 5-19 year olds in Africa - a systematic review.

Authors:  Eposi C Haddison; Leila H Abdullahi; Rudzani Muloiwa; Gregory D Hussey; Benjamin M Kagina
Journal:  F1000Res       Date:  2017-10-13

6.  Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.

Authors:  Katherine E Gallagher; Natasha Howard; Severin Kabakama; Sandra Mounier-Jack; Ulla K Griffiths; Marta Feletto; Helen E D Burchett; D Scott LaMontagne; Deborah Watson-Jones
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.